Xifaxan (rifaximin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Xifaxan (rifaximin), covering 2026-04-20 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: Rifaximin Versus No Intervention for the Treatment of IgA Monoclonal Gammopathy of Undetermined Significance [Phase 2]